Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

New research shows calcium supplements don’t raise dementia risk in older women, offering reassurance about their long-term ...

New 2025 observational research on adults aged 40-65 finds BurnPeak’s Triple-BHB formulation supports measurable fat reduction, energy balance, and appetite control without stimulants.

Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled ‘Descriptive ...

In a large real-world Italian cohort, GLP-1 receptor agonist therapy led to measurable rates of type 2 diabetes remission, ...

Menopause, the natural cessation of periods due to lower hormone levels, typically occurs between the ages of 45 and 55. The ...

Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the use of hormone ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The OPTIMISE-CKD CEE study, officially titled ‘A ...

A study of an urban US population reports a sharp decline in dermatologic disease in people with newly diagnosed HIV and ...

“The researchers found that people in the groups who accumulated more of their daily steps in longer bouts had better health outcomes than those who more commonly took shorter bouts of steps. Those ...